NASDAQ: SPRB
Spruce Biosciences Inc Stock

$0.40+0.00 (+0%)
Updated Feb 11, 2025
SPRB Price
$0.40
Fair Value Price
N/A
Market Cap
$16.64M
52 Week Low
$0.34
52 Week High
$5.95
P/E
-0.43x
P/B
0.32x
P/S
2.76x
PEG
N/A
Dividend Yield
N/A
Revenue
$7.10M
Earnings
-$39.43M
Gross Margin
100%
Operating Margin
-590.35%
Profit Margin
-555.2%
Debt to Equity
0.26
Operating Cash Flow
-$46M
Beta
1.22
Next Earnings
Mar 11, 2025
Ex-Dividend
N/A
Next Dividend
N/A

SPRB Overview

Spruce Biosciences Incorporated develops and commercializes novel therapies for rare endocrine disorders. It is developing Tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from Congenital Adrenal Hyperplasia (CAH), which is in a Phase 2b clinical trial. Spruce Biosciences was incorporated in 2014 and is headquartered in Daly City, CA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine SPRB's potential to beat the market

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
SPRB
Ranked
Unranked of 558

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important SPRB news, forecast changes, insider trades & much more!

SPRB News

Overview

Due Diligence Score

Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SPRB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SPRB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SPRB is good value based on its book value relative to its share price (0.32x), compared to the US Biotechnology industry average (4.8x)
P/B vs Industry Valuation
SPRB is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SPRB due diligence checks available for Premium users.

Valuation

SPRB price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.43x
Industry
-137.9x
Market
31.02x

SPRB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.32x
Industry
4.8x
SPRB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SPRB's financial health

Profit margin

Revenue
$602.0k
Net Income
-$8.7M
Profit Margin
-1,440.4%
SPRB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SPRB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$65.1M
Liabilities
$13.5M
Debt to equity
0.26
SPRB's short-term assets ($63.57M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SPRB's short-term assets ($63.57M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SPRB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.2M
Investing
$0.0
Financing
-$405.0k
SPRB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SPRB vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
SPRB$16.64M+1.51%-0.43x0.32x
NRXSC$16.47M-7.81%-1.28x-9.18x
FBRXC$16.24M+0.77%-0.68x1.73x
AFMDD$17.05M0.00%-0.21x0.93x
CLDID$15.96M-7.58%-0.79x-1.55x

Spruce Biosciences Stock FAQ

What is Spruce Biosciences's quote symbol?

(NASDAQ: SPRB) Spruce Biosciences trades on the NASDAQ under the ticker symbol SPRB. Spruce Biosciences stock quotes can also be displayed as NASDAQ: SPRB.

If you're new to stock investing, here's how to buy Spruce Biosciences stock.

What is the 52 week high and low for Spruce Biosciences (NASDAQ: SPRB)?

(NASDAQ: SPRB) Spruce Biosciences's 52-week high was $5.95, and its 52-week low was $0.34. It is currently -93.23% from its 52-week high and 17.84% from its 52-week low.

How much is Spruce Biosciences stock worth today?

(NASDAQ: SPRB) Spruce Biosciences currently has 41,302,599 outstanding shares. With Spruce Biosciences stock trading at $0.40 per share, the total value of Spruce Biosciences stock (market capitalization) is $16.64M.

Spruce Biosciences stock was originally listed at a price of $17.00 in Oct 9, 2020. If you had invested in Spruce Biosciences stock at $17.00, your return over the last 4 years would have been -97.63%, for an annualized return of -60.76% (not including any dividends or dividend reinvestments).

How much is Spruce Biosciences's stock price per share?

(NASDAQ: SPRB) Spruce Biosciences stock price per share is $0.40 today (as of Feb 11, 2025).

What is Spruce Biosciences's Market Cap?

(NASDAQ: SPRB) Spruce Biosciences's market cap is $16.64M, as of Feb 12, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Spruce Biosciences's market cap is calculated by multiplying SPRB's current stock price of $0.40 by SPRB's total outstanding shares of 41,302,599.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.